Erik Larsson
1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Heterogeneous Distribution and Absorbed Dose of Radiolabeled Nanoparticles and Colloids in Sentinel Lymph Nodes
(
- Contribution to journal › Article
- 2024
-
Mark
Pareto optimization of SPECT acquisition and reconstruction settings for 177Lu activity quantification
(
- Contribution to journal › Article
-
Mark
Bias and precision of SPECT-based 177Lu activity-concentration estimation using a ring-configured solid-state versus a dual-headed anger system
(
- Contribution to journal › Article
- 2022
-
Mark
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
(
- Contribution to journal › Article
- 2019
-
Mark
Albumin infusion rate and plasma volume expansion : A randomized clinical trial in postoperative patients after major surgery
(
- Contribution to journal › Article
-
Mark
Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics
(
- Contribution to journal › Article
- 2018
-
Mark
Quantitative analysis of phantom studies of 111In and 68Ga imaging of neuroendocrine tumours
(
- Contribution to journal › Article
- 2016
-
Mark
Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide 177Lu Compared to Alpha Particles and Gamma Rays.
(
- Contribution to journal › Article
-
Mark
Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2
(
- Contribution to journal › Article
-
Mark
The importance of albumin infusion rate for plasma volume expansion following major abdominal surgery - AIR: Study protocol for a randomised controlled trial
(
- Contribution to journal › Article